Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Israeli study: 2nd vaccine booster significantly lowers COVID death rate

Published 03/27/2022, 07:44 AM
Updated 03/27/2022, 07:45 AM
© Reuters. FILE PHOTO: 89-year-old Yodit Ben Ari receives a fourth dose of the coronavirus disease (COVID-19) vaccine following a vaccination party after Israel approved a second booster shot for the immunocompromised, people over 60 years and medical staff in a ret
MRNA
-

JERUSALEM (Reuters) - Senior citizens who received a second booster of the Pfizer–BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only, a study from Israel showed on Sunday.

The country's largest healthcare provider, Clalit Health Services, said the 40-day study included more than half a million people aged 60 to 100.

Some 58% of participants had received a second booster - or two shots in addition to the basic two-shot regimen. The remainder had received only one booster. Researchers recorded 92 deaths among the first group and 232 deaths among the second, smaller group.

"The main conclusion is that the second booster is lifesaving," said Ronen Arbel, Health Outcomes Researcher at Clalit and Sapir College.

© Reuters. FILE PHOTO: 89-year-old Yodit Ben Ari receives a fourth dose of the coronavirus disease (COVID-19) vaccine following a vaccination party after Israel approved a second booster shot for the immunocompromised, people over 60 years and medical staff in a retirement home in Netanya, Israel January 5, 2022. REUTERS/Ammar Awad

The report was issued as a preprint and has not been peer-reviewed. The research excluded people who received rival Moderna (NASDAQ:MRNA)'s vaccine and those who had taken oral anti-COVID therapy.

Israeli health officials have put out a number of studies on vaccine efficacy throughout the pandemic that have impacted policymaking in other countries.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.